Skip to main content

Mammographic density: intersection of advocacy, science, and clinical practice.

Publication ,  Journal Article
Tossas-Milligan, K; Shalabi, S; Jones, V; Keely, PJ; Conklin, MW; Eliceiri, KW; Winn, R; Sistrunk, C; Geradts, J; Miranda-Carboni, G; Yee, LD ...
Published in: Curr Breast Cancer Rep
September 2019

PURPOSE: Here we aim to review the association between mammographic density, collagen structure and breast cancer risk. FINDINGS: While mammographic density is a strong predictor of breast cancer risk in populations, studies by Boyd show that mammographic density does not predict breast cancer risk in individuals. Mammographic density is affected by age, parity, menopausal status, race/ethnicity, and body mass index (BMI).New studies normalize mammographic density to BMI may provide a more accurate way to compare mammographic density in women of diverse race and ethnicity. Preclinical and tissue-based studies have investigated the role collagen composition and structure in predicting breast cancer risk. There is emerging evidence that collagen structure may activate signaling pathways associated with aggressive breast cancer biology. SUMMARY: Measurement of film mammographic density does not adequately capture the complex signaling that occurs in women with at-risk collagen. New ways to measure at-risk collagen potentially can provide a more accurate view of risk.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Curr Breast Cancer Rep

DOI

ISSN

1943-4588

Publication Date

September 2019

Volume

11

Issue

3

Start / End Page

100 / 110

Location

United States

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Tossas-Milligan, K., Shalabi, S., Jones, V., Keely, P. J., Conklin, M. W., Eliceiri, K. W., … Seewaldt, V. L. (2019). Mammographic density: intersection of advocacy, science, and clinical practice. Curr Breast Cancer Rep, 11(3), 100–110. https://doi.org/10.1007/s12609-019-00316-4
Tossas-Milligan, Katherine, Sundus Shalabi, Veronica Jones, Patricia J. Keely, Matthew W. Conklin, Kevin W. Eliceiri, Robert Winn, et al. “Mammographic density: intersection of advocacy, science, and clinical practice.Curr Breast Cancer Rep 11, no. 3 (September 2019): 100–110. https://doi.org/10.1007/s12609-019-00316-4.
Tossas-Milligan K, Shalabi S, Jones V, Keely PJ, Conklin MW, Eliceiri KW, et al. Mammographic density: intersection of advocacy, science, and clinical practice. Curr Breast Cancer Rep. 2019 Sep;11(3):100–10.
Tossas-Milligan, Katherine, et al. “Mammographic density: intersection of advocacy, science, and clinical practice.Curr Breast Cancer Rep, vol. 11, no. 3, Sept. 2019, pp. 100–10. Pubmed, doi:10.1007/s12609-019-00316-4.
Tossas-Milligan K, Shalabi S, Jones V, Keely PJ, Conklin MW, Eliceiri KW, Winn R, Sistrunk C, Geradts J, Miranda-Carboni G, Dietze EC, Yee LD, Seewaldt VL. Mammographic density: intersection of advocacy, science, and clinical practice. Curr Breast Cancer Rep. 2019 Sep;11(3):100–110.

Published In

Curr Breast Cancer Rep

DOI

ISSN

1943-4588

Publication Date

September 2019

Volume

11

Issue

3

Start / End Page

100 / 110

Location

United States

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis